DEVELOPING
Importance
45
Trust
71
Urgency
65
CLINICAL TRIAL
Lexaria targets mid-June start for 5-week oral semaglutide study - Stock Titan
Lexaria plans to start a 5-week study of an oral form of semaglutide in mid-June. The study will test whether this pill version works as a weight-loss treatment.
Analysis
A small company is testing its own pill version of semaglutide. Early-stage work like this rarely moves the market, but oral GLP-1s are a hot area.
- Lexaria plans to start a 5-week oral semaglutide study in mid-June
- Study will test the pill as a weight-loss treatment
Semaglutide News1mo
Read